Successful ruxolitinib administration for a patient with steroid‐refractory idiopathic pneumonia syndrome following hematopoietic stem cell transplantation: A case report and literature review

Idiopathic pneumonia syndrome (IPS) is an acute lung complication observed after the early posthematopoietic stem cell transplantation (HSCT) period. Ruxolitinib was effective for a patient with myelodysplastic syndrome who developed severe IPS after second HSCT. No severe adverse effects were obser...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomomasa, Dan, Isoda, Takeshi, Mitsuiki, Noriko, Yamashita, Motoi, Morishita, Aoi, Tomoda, Takahiro, Okano, Tsubasa, Endo, Akifumi, Kamiya, Takahiro, Yanagimachi, Masakatsu, Imai, Kohsuke, Kanegane, Hirokazu, Takagi, Masatoshi, Morio, Tomohiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693824/
https://www.ncbi.nlm.nih.gov/pubmed/34987813
http://dx.doi.org/10.1002/ccr3.5242
_version_ 1784619220806402048
author Tomomasa, Dan
Isoda, Takeshi
Mitsuiki, Noriko
Yamashita, Motoi
Morishita, Aoi
Tomoda, Takahiro
Okano, Tsubasa
Endo, Akifumi
Kamiya, Takahiro
Yanagimachi, Masakatsu
Imai, Kohsuke
Kanegane, Hirokazu
Takagi, Masatoshi
Morio, Tomohiro
author_facet Tomomasa, Dan
Isoda, Takeshi
Mitsuiki, Noriko
Yamashita, Motoi
Morishita, Aoi
Tomoda, Takahiro
Okano, Tsubasa
Endo, Akifumi
Kamiya, Takahiro
Yanagimachi, Masakatsu
Imai, Kohsuke
Kanegane, Hirokazu
Takagi, Masatoshi
Morio, Tomohiro
author_sort Tomomasa, Dan
collection PubMed
description Idiopathic pneumonia syndrome (IPS) is an acute lung complication observed after the early posthematopoietic stem cell transplantation (HSCT) period. Ruxolitinib was effective for a patient with myelodysplastic syndrome who developed severe IPS after second HSCT. No severe adverse effects were observed. Ruxolitinib may be an alternative choice for HSCT‐related IPS.
format Online
Article
Text
id pubmed-8693824
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86938242022-01-04 Successful ruxolitinib administration for a patient with steroid‐refractory idiopathic pneumonia syndrome following hematopoietic stem cell transplantation: A case report and literature review Tomomasa, Dan Isoda, Takeshi Mitsuiki, Noriko Yamashita, Motoi Morishita, Aoi Tomoda, Takahiro Okano, Tsubasa Endo, Akifumi Kamiya, Takahiro Yanagimachi, Masakatsu Imai, Kohsuke Kanegane, Hirokazu Takagi, Masatoshi Morio, Tomohiro Clin Case Rep Case Report Idiopathic pneumonia syndrome (IPS) is an acute lung complication observed after the early posthematopoietic stem cell transplantation (HSCT) period. Ruxolitinib was effective for a patient with myelodysplastic syndrome who developed severe IPS after second HSCT. No severe adverse effects were observed. Ruxolitinib may be an alternative choice for HSCT‐related IPS. John Wiley and Sons Inc. 2021-12-22 /pmc/articles/PMC8693824/ /pubmed/34987813 http://dx.doi.org/10.1002/ccr3.5242 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Tomomasa, Dan
Isoda, Takeshi
Mitsuiki, Noriko
Yamashita, Motoi
Morishita, Aoi
Tomoda, Takahiro
Okano, Tsubasa
Endo, Akifumi
Kamiya, Takahiro
Yanagimachi, Masakatsu
Imai, Kohsuke
Kanegane, Hirokazu
Takagi, Masatoshi
Morio, Tomohiro
Successful ruxolitinib administration for a patient with steroid‐refractory idiopathic pneumonia syndrome following hematopoietic stem cell transplantation: A case report and literature review
title Successful ruxolitinib administration for a patient with steroid‐refractory idiopathic pneumonia syndrome following hematopoietic stem cell transplantation: A case report and literature review
title_full Successful ruxolitinib administration for a patient with steroid‐refractory idiopathic pneumonia syndrome following hematopoietic stem cell transplantation: A case report and literature review
title_fullStr Successful ruxolitinib administration for a patient with steroid‐refractory idiopathic pneumonia syndrome following hematopoietic stem cell transplantation: A case report and literature review
title_full_unstemmed Successful ruxolitinib administration for a patient with steroid‐refractory idiopathic pneumonia syndrome following hematopoietic stem cell transplantation: A case report and literature review
title_short Successful ruxolitinib administration for a patient with steroid‐refractory idiopathic pneumonia syndrome following hematopoietic stem cell transplantation: A case report and literature review
title_sort successful ruxolitinib administration for a patient with steroid‐refractory idiopathic pneumonia syndrome following hematopoietic stem cell transplantation: a case report and literature review
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693824/
https://www.ncbi.nlm.nih.gov/pubmed/34987813
http://dx.doi.org/10.1002/ccr3.5242
work_keys_str_mv AT tomomasadan successfulruxolitinibadministrationforapatientwithsteroidrefractoryidiopathicpneumoniasyndromefollowinghematopoieticstemcelltransplantationacasereportandliteraturereview
AT isodatakeshi successfulruxolitinibadministrationforapatientwithsteroidrefractoryidiopathicpneumoniasyndromefollowinghematopoieticstemcelltransplantationacasereportandliteraturereview
AT mitsuikinoriko successfulruxolitinibadministrationforapatientwithsteroidrefractoryidiopathicpneumoniasyndromefollowinghematopoieticstemcelltransplantationacasereportandliteraturereview
AT yamashitamotoi successfulruxolitinibadministrationforapatientwithsteroidrefractoryidiopathicpneumoniasyndromefollowinghematopoieticstemcelltransplantationacasereportandliteraturereview
AT morishitaaoi successfulruxolitinibadministrationforapatientwithsteroidrefractoryidiopathicpneumoniasyndromefollowinghematopoieticstemcelltransplantationacasereportandliteraturereview
AT tomodatakahiro successfulruxolitinibadministrationforapatientwithsteroidrefractoryidiopathicpneumoniasyndromefollowinghematopoieticstemcelltransplantationacasereportandliteraturereview
AT okanotsubasa successfulruxolitinibadministrationforapatientwithsteroidrefractoryidiopathicpneumoniasyndromefollowinghematopoieticstemcelltransplantationacasereportandliteraturereview
AT endoakifumi successfulruxolitinibadministrationforapatientwithsteroidrefractoryidiopathicpneumoniasyndromefollowinghematopoieticstemcelltransplantationacasereportandliteraturereview
AT kamiyatakahiro successfulruxolitinibadministrationforapatientwithsteroidrefractoryidiopathicpneumoniasyndromefollowinghematopoieticstemcelltransplantationacasereportandliteraturereview
AT yanagimachimasakatsu successfulruxolitinibadministrationforapatientwithsteroidrefractoryidiopathicpneumoniasyndromefollowinghematopoieticstemcelltransplantationacasereportandliteraturereview
AT imaikohsuke successfulruxolitinibadministrationforapatientwithsteroidrefractoryidiopathicpneumoniasyndromefollowinghematopoieticstemcelltransplantationacasereportandliteraturereview
AT kaneganehirokazu successfulruxolitinibadministrationforapatientwithsteroidrefractoryidiopathicpneumoniasyndromefollowinghematopoieticstemcelltransplantationacasereportandliteraturereview
AT takagimasatoshi successfulruxolitinibadministrationforapatientwithsteroidrefractoryidiopathicpneumoniasyndromefollowinghematopoieticstemcelltransplantationacasereportandliteraturereview
AT moriotomohiro successfulruxolitinibadministrationforapatientwithsteroidrefractoryidiopathicpneumoniasyndromefollowinghematopoieticstemcelltransplantationacasereportandliteraturereview

Ejemplares similares